{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T18:09:57Z","timestamp":1794593397940,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8096","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,1,8]]},"DOI":"10.1038\/s41586-025-09755-9","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:03:13Z","timestamp":1762358593000},"page":"423-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Adenosine signalling drives antidepressant actions of ketamine and ECT"],"prefix":"10.1038","volume":"649","author":[{"given":"Chenyu","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojiang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2027-5194","authenticated-orcid":false,"given":"Zhaofa","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-1055","authenticated-orcid":false,"given":"Wooping","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9166-9919","authenticated-orcid":false,"given":"Yulong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3415-5612","authenticated-orcid":false,"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3535-6624","authenticated-orcid":false,"given":"Minmin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"9755_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman, R. M. et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351\u2013354 (2000).","journal-title":"Biol. Psychiatry"},{"key":"9755_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate, C. A. Jr et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63, 856\u2013864 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"9755_CR3","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1056\/NEJMct075234","volume":"357","author":"SH Lisanby","year":"2007","unstructured":"Lisanby, S. H. Electroconvulsive therapy for depression. N. Engl. J. Med. 357, 1939\u20131945 (2007).","journal-title":"N. Engl. J. Med."},{"key":"9755_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry, A. E. et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91\u201395 (2011).","journal-title":"Nature"},{"key":"9755_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li, N. et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959\u2013964 (2010).","journal-title":"Science"},{"key":"9755_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-03047-0","volume":"590","author":"A Aguilar-Valles","year":"2021","unstructured":"Aguilar-Valles, A. et al. Antidepressant actions of ketamine engage cell-specific translation via eIF4E. Nature 590, 315\u2013319 (2021).","journal-title":"Nature"},{"key":"9755_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto, P. C. et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell 184, 1299\u20131313 (2021).","journal-title":"Cell"},{"key":"9755_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8078","volume":"364","author":"RN Moda-Sava","year":"2019","unstructured":"Moda-Sava, R. N. et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science 364, eaat8078 (2019).","journal-title":"Science"},{"key":"9755_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-med-051322-120608","volume":"75","author":"JW Kim","year":"2024","unstructured":"Kim, J. W., Suzuki, K., Kavalali, E. T. & Monteggia, L. M. Ketamine: mechanisms and relevance to treatment of depression. Annu. Rev. Med. 75, 129\u2013143 (2024).","journal-title":"Annu. Rev. Med."},{"key":"9755_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos, P. et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533, 481\u2013486 (2016).","journal-title":"Nature"},{"key":"9755_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature25509","volume":"554","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature 554, 317\u2013322 (2018).","journal-title":"Nature"},{"key":"9755_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","volume":"79","author":"NA Anis","year":"1983","unstructured":"Anis, N. A., Berry, S. C., Burton, N. R. & Lodge, D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br. J. Pharmacol. 79, 565\u2013575 (1983).","journal-title":"Br. J. Pharmacol."},{"key":"9755_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos, P. & Gould, T. D. Mechanisms of ketamine action as an antidepressant. Mol. Psychiatry 23, 801\u2013811 (2018).","journal-title":"Mol. Psychiatry"},{"key":"9755_CR14","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","volume":"101","author":"JH Krystal","year":"2019","unstructured":"Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S. & Duman, R. S. Ketamine: a paradigm shift for depression research and treatment. Neuron 101, 774\u2013778 (2019).","journal-title":"Neuron"},{"key":"9755_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.biopsych.2021.11.016","volume":"92","author":"AM Leaver","year":"2022","unstructured":"Leaver, A. M., Espinoza, R., Wade, B. & Narr, K. L. Parsing the network mechanisms of electroconvulsive therapy. Biol. Psychiatry 92, 193\u2013203 (2022).","journal-title":"Biol. Psychiatry"},{"key":"9755_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","volume":"24","author":"TV Dunwiddie","year":"2001","unstructured":"Dunwiddie, T. V. & Masino, S. A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24, 31\u201355 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"9755_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-801022-8.00001-5","volume":"119","author":"JF Chen","year":"2014","unstructured":"Chen, J. F., Lee, C. F. & Chern, Y. Adenosine receptor neurobiology: overview. Int. Rev. Neurobiol. 119, 1\u201349 (2014).","journal-title":"Int. Rev. Neurobiol."},{"key":"9755_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","volume":"28","author":"GR Fries","year":"2023","unstructured":"Fries, G. R., Saldana, V. A., Finnstein, J. & Rein, T. Molecular pathways of major depressive disorder converge on the synapse. Mol. Psychiatry 28, 284\u2013297 (2023).","journal-title":"Mol. Psychiatry"},{"key":"9755_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jnc.14841","volume":"151","author":"D van Calker","year":"2019","unstructured":"van Calker, D., Biber, K., Domschke, K. & Serchov, T. The role of adenosine receptors in mood and anxiety disorders. J. Neurochem. 151, 11\u201327 (2019).","journal-title":"J. Neurochem."},{"key":"9755_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neuron.2015.07.010","volume":"87","author":"t serchov","year":"2015","unstructured":"serchov, t. et al. Increased signaling via adenosine A1 receptors, sleep deprivation, imipramine, and ketamine inhibit depressive-like behavior via induction of Homer1a. Neuron 87, 549\u2013562 (2015).","journal-title":"Neuron"},{"key":"9755_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.136","volume":"3","author":"DJ Hines","year":"2013","unstructured":"Hines, D. J., Schmitt, L. I., Hines, R. M., Moss, S. J. & Haydon, P. G. Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling. Transl. Psychiatry 3, e212 (2013).","journal-title":"Transl. Psychiatry"},{"key":"9755_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/157015909789152164","volume":"7","author":"SA Masino","year":"2009","unstructured":"Masino, S. A., Kawamura, M., Wasser, C. D., Pomeroy, L. T. & Ruskin, D. N. Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity. Curr. Neuropharmacol. 7, 257\u2013268 (2009).","journal-title":"Curr. Neuropharmacol."},{"key":"9755_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","volume":"79","author":"S Latini","year":"2001","unstructured":"Latini, S. & Pedata, F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79, 463\u2013484 (2001).","journal-title":"J. Neurochem."},{"key":"9755_CR24","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F. & Varani, K. Pharmacology of adenosine receptors: the state of the art. Physiol. Rev. 98, 1591\u20131625 (2018).","journal-title":"Physiol. Rev."},{"key":"9755_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37601-x","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. Lateral septum adenosine A2A receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula. Nat. Commun. 14, 1880 (2023).","journal-title":"Nat. Commun."},{"key":"9755_CR26","first-page":"H235","volume":"241","author":"HR Winn","year":"1981","unstructured":"Winn, H. R., Rubio, R. & Berne, R. M. Brain adenosine concentration during hypoxia in rats. Am. J. Physiol. 241, H235\u2013H242 (1981).","journal-title":"Am. J. Physiol."},{"key":"9755_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/20961790.2017.1285219","volume":"2","author":"RJ Dinis-Oliveira","year":"2017","unstructured":"Dinis-Oliveira, R. J. Metabolism and metabolomics of ketamine: a toxicological approach. Forensic Sci. Res. 2, 2\u201310 (2017).","journal-title":"Forensic Sci. Res."},{"key":"9755_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"KA Jacobson","year":"2006","unstructured":"Jacobson, K. A. & Gao, Z. G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247\u2013264 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9755_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"JF Chen","year":"2013","unstructured":"Chen, J. F., Eltzschig, H. K. & Fredholm, B. B. Adenosine receptors as drug targets\u2014what are the challenges? Nat. Rev. Drug Discov. 12, 265\u2013286 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"9755_CR30","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1038\/s41380-021-01246-3","volume":"26","author":"V Lazarevic","year":"2021","unstructured":"Lazarevic, V., Yang, Y., Flais, I. & Svenningsson, P. Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors. Mol. Psychiatry 26, 7425\u20137435 (2021).","journal-title":"Mol. Psychiatry"},{"key":"9755_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11302-015-9446-7","volume":"11","author":"MP Cunha","year":"2015","unstructured":"Cunha, M. P. et al. Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A1 and A2A receptor activation. Purinergic Signal. 11, 215\u2013227 (2015).","journal-title":"Purinergic Signal."},{"key":"9755_CR32","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/npp.2013.71","volume":"38","author":"AK Walker","year":"2013","unstructured":"Walker, A. K. et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice. Neuropsychopharmacology 38, 1609\u20131616 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"9755_CR33","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1038\/s41380-024-02851-8","volume":"30","author":"H Li","year":"2025","unstructured":"Li, H. et al. Astrocytes release ATP\/ADP and glutamate in flashes via vesicular exocytosis. Mol. Psychiatry 30, 2475\u20132489 (2025).","journal-title":"Mol. Psychiatry"},{"key":"9755_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","volume":"102","author":"C Bjorkholm","year":"2016","unstructured":"Bjorkholm, C. & Monteggia, L. M. BDNF\u2014a key transducer of antidepressant effects. Neuropharmacology 102, 72\u201379 (2016).","journal-title":"Neuropharmacology"},{"key":"9755_CR35","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41593-021-00868-8","volume":"24","author":"JW Kim","year":"2021","unstructured":"Kim, J. W. et al. Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation. Nat. Neurosci. 24, 1100\u20131109 (2021).","journal-title":"Nat. Neurosci."},{"key":"9755_CR36","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin, G. G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783, 673\u2013694 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"9755_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nmeth.1288","volume":"6","author":"J Berg","year":"2009","unstructured":"Berg, J., Hung, Y. P. & Yellen, G. A genetically encoded fluorescent reporter of ATP:ADP ratio. Nat. Methods 6, 161\u2013166 (2009).","journal-title":"Nat. Methods"},{"key":"9755_CR38","doi-asserted-by":"publisher","first-page":"672182","DOI":"10.3389\/fphar.2021.672182","volume":"12","author":"M Garcia-Gil","year":"2021","unstructured":"Garcia-Gil, M., Camici, M., Allegrini, S., Pesi, R. & Tozzi, M. G. Metabolic aspects of adenosine functions in the brain. Front. Pharmacol. 12, 672182 (2021).","journal-title":"Front. Pharmacol."},{"key":"9755_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos, P. et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol. Rev. 70, 621\u2013660 (2018).","journal-title":"Pharmacol. Rev."},{"key":"9755_CR40","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","volume":"231","author":"G Fond","year":"2014","unstructured":"Fond, G. et al. Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology 231, 3663\u20133676 (2014).","journal-title":"Psychopharmacology"},{"key":"9755_CR41","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1176\/appi.ajp.2012.12050648","volume":"169","author":"CH Kellner","year":"2012","unstructured":"Kellner, C. H. et al. ECT in treatment-resistant depression. Am. J. Psychiatry 169, 1238\u20131244 (2012).","journal-title":"Am. J. Psychiatry"},{"key":"9755_CR42","doi-asserted-by":"publisher","first-page":"R1181","DOI":"10.1152\/ajpregu.00208.2014","volume":"307","author":"A Navarrete-Opazo","year":"2014","unstructured":"Navarrete-Opazo, A. & Mitchell, G. S. Therapeutic potential of intermittent hypoxia: a matter of dose. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R1181\u2013R1197 (2014).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"9755_CR43","doi-asserted-by":"publisher","first-page":"364","DOI":"10.55782\/ane-2015-2041","volume":"75","author":"M Duszczyk","year":"2015","unstructured":"Duszczyk, M. et al. Antidepressant-like and anxiolytic-like effects of mild hypobaric hypoxia in mice: possible involvement of neuropeptide Y. Acta Neurobiol. Exp. 75, 364\u2013371 (2015).","journal-title":"Acta Neurobiol. Exp."},{"key":"9755_CR44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1471-4159.2007.05046.x","volume":"104","author":"MT Tebano","year":"2008","unstructured":"Tebano, M. T. et al. Adenosine A2A receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. J. Neurochem. 104, 279\u2013286 (2008).","journal-title":"J. Neurochem."},{"key":"9755_CR45","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.neuropharm.2008.01.011","volume":"54","author":"BM Fontinha","year":"2008","unstructured":"Fontinha, B. M., Diogenes, M. J., Ribeiro, J. A. & Sebastiao, A. M. Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine. Neuropharmacology 54, 924\u2013933 (2008).","journal-title":"Neuropharmacology"},{"key":"9755_CR46","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41593-023-01436-y","volume":"26","author":"T Su","year":"2023","unstructured":"Su, T., Lu, Y., Fu, C., Geng, Y. & Chen, Y. GluN2A mediates ketamine-induced rapid antidepressant-like responses. Nat. Neurosci. 26, 1751\u20131761 (2023).","journal-title":"Nat. Neurosci."},{"key":"9755_CR47","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman, R. S., Aghajanian, G. K., Sanacora, G. & Krystal, J. H. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat. Med. 22, 238\u2013249 (2016).","journal-title":"Nat. Med."},{"key":"9755_CR48","doi-asserted-by":"publisher","first-page":"e100074","DOI":"10.1136\/gpsych-2019-100074","volume":"32","author":"A Somani","year":"2019","unstructured":"Somani, A. & Kar, S. K. Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far. Gen. Psychiatr. 32, e100074 (2019).","journal-title":"Gen. Psychiatr."},{"key":"9755_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bcp.2019.06.008","volume":"166","author":"JP Lopes","year":"2019","unstructured":"Lopes, J. P., Pliassova, A. & Cunha, R. A. The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A1 and A2A receptors. Biochem. Pharmacol. 166, 313\u2013321 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"9755_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm, B. B., Battig, K., Holmen, J., Nehlig, A. & Zvartau, E. E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83\u2013133 (1999).","journal-title":"Pharmacol. Rev."},{"key":"9755_CR51","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41592-022-01547-7","volume":"19","author":"R Lin","year":"2022","unstructured":"Lin, R. et al. Directed evolution of adeno-associated virus for efficient gene delivery to microglia. Nat. Methods 19, 976\u2013985 (2022).","journal-title":"Nat. Methods"},{"key":"9755_CR52","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1016\/j.neuron.2023.08.022","volume":"111","author":"Z Yuan","year":"2023","unstructured":"Yuan, Z. et al. A corticoamygdalar pathway controls reward devaluation and depression using dynamic inhibition code. Neuron 111, 3837\u20133853 (2023).","journal-title":"Neuron"},{"key":"9755_CR53","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.neuron.2018.01.005","volume":"97","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Hypothalamic circuits for predation and evasion. Neuron 97, 911\u2013924 (2018).","journal-title":"Neuron"},{"key":"9755_CR54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2212387120","volume":"120","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. Neuronal activity-induced, equilibrative nucleoside transporter-dependent, somatodendritic adenosine release revealed by a GRAB sensor. Proc. Natl Acad. Sci. USA 120, e2212387120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9755_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb0556","volume":"369","author":"W Peng","year":"2020","unstructured":"Peng, W. et al. Regulation of sleep homeostasis mediator adenosine by basal forebrain glutamatergic neurons. Science 369, eabb0556 (2020).","journal-title":"Science"},{"key":"9755_CR56","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.neuron.2021.11.027","volume":"110","author":"Z Wu","year":"2022","unstructured":"Wu, Z. et al. A sensitive GRAB sensor for detecting extracellular ATP in vitro and in vivo. Neuron 110, 770\u2013782 (2022).","journal-title":"Neuron"},{"key":"9755_CR57","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jnr.20754","volume":"83","author":"KS Kim","year":"2006","unstructured":"Kim, K. S. & Han, P. L. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J. Neurosci. Res. 83, 497\u2013507 (2006).","journal-title":"J. Neurosci. Res."},{"key":"9755_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/9780470942390.mo110176","volume":"2","author":"TR Powell","year":"2012","unstructured":"Powell, T. R., Fernandes, C. & Schalkwyk, L. C. Depression-related behavioral tests. Curr. Protoc. Mouse Biol. 2, 119\u2013127 (2012).","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"9755_CR59","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1016\/j.cell.2025.04.010","volume":"188","author":"Q Xin","year":"2025","unstructured":"Xin, Q. et al. Neuron\u2013astrocyte coupling in lateral habenula mediates depressive-like behaviors. Cell 188, 3291\u20133309 (2025).","journal-title":"Cell"},{"key":"9755_CR60","doi-asserted-by":"publisher","first-page":"e0184603","DOI":"10.1371\/journal.pone.0184603","volume":"12","author":"EM van Buel","year":"2017","unstructured":"van Buel, E. M. et al. Mouse repeated electroconvulsive seizure (ECS) does not reverse social stress effects but does induce behavioral and hippocampal changes relevant to electroconvulsive therapy (ECT) side-effects in the treatment of depression. PLoS ONE 12, e0184603 (2017).","journal-title":"PLoS ONE"},{"key":"9755_CR61","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s11427-022-2122-0","volume":"65","author":"R Dai","year":"2022","unstructured":"Dai, R. et al. A neuropsin-based optogenetic tool for precise control of Gq signaling. Sci. China Life Sci. 65, 1271\u20131284 (2022).","journal-title":"Sci. China Life Sci."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09755-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09755-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09755-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:02:35Z","timestamp":1767830555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09755-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":61,"journal-issue":{"issue":"8096","published-print":{"date-parts":[[2026,1,8]]}},"alternative-id":["9755"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09755-9","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.L. is the scientific founder of ThinkerTech Biotech, GenAns Biotech and Neucyber Neurotech. This relationship did not influence this study. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}